Tectonic Therapeutics TECX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$25.24M-58.7% | -$19.23M-55.4% | -$19.04M-7.4% | -$19.98M-57.7% | -$15.91M-4.5% | ||
| $304K-15.6% | $333K-34.4% | $342K-19.3% | $340K+1.2% | $360K-4.5% | ||
| $3.21M+52.4% | $2.99M+168% | $2.82M+70.7% | $2.59M+542% | $2.1M+555% | ||
| -$23K— | $0— | -$93K— | -$60K— | $0— | ||
| $1.38M-12.7% | —— | —— | $137K+109% | $1.58M+4.9% | ||
| $1.63M+148% | —— | —— | —— | -$3.42M-347% | ||
| $23K+264% | -$14K+98.0% | —— | —— | -$14K+41.7% | ||
| $496K-2.9% | $548K— | $535K+73.7% | $524K+74.1% | $511K+73.8% | ||
| -$147K+73.4% | -$593K— | -$581K-70.4% | -$568K-70.1% | -$553K-70.7% | ||
| -$18.41M-40.7% | -$14.46M+14.0% | -$17.82M+9.1% | -$14.72M-10.0% | -$13.08M-41.1% | ||
| $19K-29.6% | —— | $181K+18.3% | —— | $27K+575% | ||
| —— | —— | $15K— | —— | —— | ||
| -$19K+29.6% | $0+100% | -$166K-8.5% | $55K+1,275% | -$27K-575% | ||
| $100K-89.7% | $59K-93.4% | $6K-92.2% | $194K-69.9% | $972K+24,200% | ||
| $105K-11.0% | $127K+10.4% | $123K+2.5% | $121K-0.8% | $118K0.0% | ||
| $412K— | —— | —— | $17K— | $0— | ||
| $847K-99.5% | —— | —— | —— | $178.12M+26,765% | ||
| $94K+1,980% | -$35K— | -$23K— | -$32K— | -$5K+93.4% | ||
| -$17.49M-111% | —— | —— | —— | $165.01M+1,747% | ||
| —— | —— | —— | —— | —— | ||
| $1.63M+148% | —— | —— | —— | -$3.42M-347% | ||
| -$147K+73.4% | -$593K— | -$581K-70.4% | -$568K-70.1% | -$553K-70.7% | ||
| $46K+102% | -$1.25M-159% | —— | —— | -$2.22M-669% | ||
| $496K-2.9% | $548K— | $535K+73.7% | $524K+74.1% | $511K+73.8% | ||
| $105K-11.0% | $127K+10.4% | $123K+2.5% | $121K-0.8% | $118K0.0% | ||
| $1.26M— | —— | —— | —— | $0— | ||
| $0-100% | —— | —— | —— | $177.27M— | ||
| -$147K+73.4% | -$593K— | -$581K-70.4% | -$568K-70.1% | -$553K-70.7% | ||
| $3.73M— | —— | —— | —— | $0— | ||
| —— | $8.75K— | $8.75K— | $8.75K— | $8.75K— | ||
| $0-100% | —— | —— | —— | $4.17M— | ||
| $79K— | —— | —— | $107K— | $0— | ||
| $21K— | —— | —— | —— | $0— | ||
| -$18.43M-40.6% | -$14.46M+14.0% | -$18M+8.9% | -$14.72M-10.0% | -$13.11M-41.3% | ||
| -$18.43M-40.6% | -$14.46M+14.0% | -$18M+8.9% | -$14.72M-10.0% | -$13.11M-41.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tectonic Therapeutics generate?
- Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
- What is Tectonic Therapeutics's free cash flow?
- After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
- Where does Tectonic Therapeutics's cash flow data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.